Jacobson Pharma Announces FY2019 Interim Results
- Written by Reporters
Profit from Operations Leapt by 40.7% to HK$158.6 Million
Declares Interim Dividend of HK1.5 cents per share
Growth Strategies to Tap Innovative Pharma Market and Expand Regional Presence
HONG KONG, CHINA - Media OutReach -21 November 2018 - Jacobson Pharma Corporation Limited ("Jacobson Pharma" or the "Company"; Stock Code:...